cri-one
Contents
100%
Your journey

13-disease-research-notes-research

Inventory item: 8459 | SKU: 2040 | Line: Blueprints

Page: https://cri-one.com/13-disease-research-notes-research.html

Owner and author: Christopher Gabriel Brown (CRI-ONE)

Record date: 8 October 2026

Approved public wording item: medical and regulatory wording follows D:/special/_inventory/descriptions-public/8459.md

1. The Record in Brief

13-disease-research-notes-research is the package Christopher Gabriel Brown (CRI-ONE) titles "Open Research: 300-Disease Mechanism Analysis Database": a computational disease-mechanism research corpus of 300 per-disease documents in 16 categories, generated by the Alchemy Data V2 elemental correlation engine over a 36,456-compound library, with its Python pipeline, drawings and data (package README.md, MANIFEST.json, CITATION.cff). Its founding method is in the owner's 2017 depositions: #148 in the 2017 catalog and #769 on printed page 181 of Invent Depositions, ISBN 978-1-979767-89-7, first shipped 24 November 2017. Three pending USPTO applications cover it: 19/540,453 (filed 13 February 2026), 19/693,405 (filed 30 May 2026) and 19/747,949 (filed 20 July 2026). It was first offered publicly on the cri-one.com store on 12 March 2026. Its text, code, data and drawings are marked "Copyright (c) 2026 Christopher Gabriel Brown. All rights reserved." in the package LICENSE.

2. Proprietary - What Is Owned and How It Is Held

Package files are named below relative to the package root folder recorded with Evidence items 1-4 in section 8. A second working copy of 407 files is held inside the 45-fda-rebuttles-and-adwork project folder. At survey on 8 October 2026 the primary folder holds 573 files across its root and nine subfolders; the package MANIFEST.json, generated 2 May 2026, records 398 delivered files in seven categories.

FamilyFilesLocation in package
Per-disease research documents300, plus 5 index and summary documentsresearch-document folder
Pipeline code60 Python scripts, 1 PowerShell orchestrator_internal/scripts/
Chemical Cooker bridge45 G-code recipes, 46 JSON files, 1 generator scriptcooker_compat/
Drawings4 figures in PDF and SVG (8 files), 1 large-format reference chartDrawings_DIABETES_300_DISEASES/, root
Data compilationstop-2000 compound JSON, CSV and summary; 6 JSON data and analysis filesfindings/, _internal/scripts/
Root documentationREADME, METHODOLOGY, SAFETY_DISCLAIMER, STATUS, CHANGELOG, LICENSE, CITATION.cff, 4 HTML pages and othersroot
Proof-of-function documents9sales-pitches/
USPTO application body1, byte-identical to the 19/747,949 papersroot

Sole ownership. The package LICENSE states that the Work is "the exclusive property of Christopher Gabriel Brown." The USPTO receipts for all three applications name Christopher Gabriel Brown as first named inventor and filer. No assignment is of record.

What a buyer receives. The package LICENSE (generated 2 May 2026) reads: "NO LICENSE IS GRANTED. No part of this Work may be copied, modified, distributed, sublicensed, sold, published, or otherwise transferred without the express written permission of the copyright holder." The owner's offer text states that the buyer "receives a copy for research and reference use" and that "Rights to the underlying inventor corpus and method claims are not conveyed" (D:/special/_inventory/descriptions-public/8459.md, IP boundary). The purchase term at https://cri-one.com/terms reads "When you buy, you buy the use of that blueprint only." and is accepted at checkout.

Secrecy measures of record (18 U.S.C. 1839(3)). The full package is delivered only to paying buyers by private download link; the delivery file of record is dated 4 September 2026 (D:/special/crione-static/delivery-v2/product_deliverables.csv). The mutual NDA is published at https://cri-one.com/nda/ and its full text travels in every delivery email (D:/special/crione-static/delivery-v2/deliver.py). The public item page carries only the description. The research corpus went public through the open-research listing of 12 March 2026 and is held by copyright and by its publication date; the USPTO application papers and the formal figure set dated 20 July 2026 travel only inside the delivered package.

3. First Art - The Earliest Dated Disclosure

DateRecordWhat it disclosesSource
2017 (copyright mark)Deposition #148Healthy-human chemistry, pH balance organ by organ, illness in reverseD:/manager/book-ocr-2017-invent-depositions/entries-clean.csv
2017 (copyright mark)Deposition #373Multi-disease study by toxic and valence testingsame; IP register line 1061
2017 (copyright mark)Deposition #486Computational predictive alchemy studiessame; IP register line 1186
24 Nov 2017Invent Depositions, Deposition #769, printed page 181Proper chemicals in an organ without poisoning the othersD:/manager/book-ocr-2017-invent-depositions/entries-index.csv
12 Jan 2026Package STATUS.md, "COMPLETE"300 documents with pathways and probability analysispackage STATUS.md
13 Feb 2026U.S. Application 19/540,453Umbrella naming the disease-discovery systemsD:/USPTO Responses/work/N417.PYMT.pdf
12 Mar 2026cri-one.com store listingThe 300-Disease Mechanism Analysis Database, publicD:/manager/export_catalog_product_20260408_165843.csv
20 Jul 2026U.S. Application 19/747,949Discovery methodology over about 36,456 compound records, 300 diseasesD:/USPTO Responses/work/N417.pdf

Deposition anchors. Deposition #148, anchored in the 2017 catalog record (entries-clean.csv) and in the master IP register D:/special/82-alchemy-calc-two/1 light trigger.txt at line 535, reads: "can we figure out the chemistry in a healthy human, then make a ph balance inside each organ including the brain and thus making chemistry balance to help the new and exciting way of working with illness in reverse?" The owner's origin record (D:/manager/book-ocr-2017-invent-depositions/origin-stories/disease-database-deposition-148.md) names #148 the origin of the 300-disease database. Deposition #769, anchored on printed book page 181 of Invent Depositions (ISBN 978-1-979767-89-7, CreateSpace, first shipped 24 November 2017 per D:/manager/book-ocr-2017-invent-depositions/MANIFEST.md) and at IP register line 1500, reads: "chemical balance relation goal is the chance to achieve the proper chemicals in the brain or an organ to make it work better and function regulatory like while not poisoning the other organs". Depositions #373 and #486 are the 2017 ancestor records of the multi-disease testing and the alchemy engine.

Defensive-publication effect. Since 16 March 2013 (AIA, first-inventor-to-file), under 35 U.S.C. 102(a)(1) a printed publication, public use, sale or other public availability before a filing date is prior art against that filing. The 2017 depositions, the 24 November 2017 book and the 12 March 2026 store listing are dated public disclosures, and each stands against every later filer on the same subject matter. A challenger must produce a dated record earlier than the 2017 depositions disclosing healthy-reference chemistry balanced organ by organ to read illness in reverse, and a dated record earlier than 13 February 2026, the filing date of 19/540,453, disclosing a 300-disease, 16-category elemental-correlation corpus derived from a 36,456-compound database. None is of record.

Prior Art Considered and Distinguished

The references considered for this product are the six portfolio-level references the prior-art register maps to it through the owner's provenance record (D:/special/_store/manager/_store/site-deploy-2026-09-23/archive-images-fix/crione-provenance.json, SKU 2040). Each is device art; the package's documented structure is a computational research corpus with none of these devices in it.

ReferenceTitle as recordedDistinction
US 4,775,876Photon recycling light emitting diodeLED device; no light-emitting structure in the package
US 2012/0305059 A1Photon recycling in an optoelectronic deviceOptoelectronic device; no optoelectronic structure in the package
US 2010/0183919 A1Quantum dot ultracapacitor and electron batteryEnergy-storage device; no storage device in the package
US 6,175,719 B1Multi-Spot-Beam SatelliteSatellite payload; no communications hardware in the package
US 7,418,236 B2Extraterrestrial Communications SystemsSatellite-terrestrial architecture; no communications hardware
US 11,258,379 B2Quantum Noise Power DevicesEnergy-harvesting device; no power device in the package

4. First to File - The USPTO Record

U.S. ApplicationFiledStatus of recordWhat it covers for this productSource
19/540,453 (Conf. [redacted])13 Feb 2026Pending; Filing Receipt mailed 27 Jul 2026Recorded title names the Disease … Discovery Systems (projects 10-13)D:/USPTO Responses/work/N417.PYMT.pdf; D:/USPTO Responses/EPSCAN/20160101_000000(14).PDF
19/693,405 (Conf. [redacted])30 May 2026Pending; Filing Receipt mailed 25 Jun 2026Project 13 (300 diseases) in the as-filed project catalogD:/USPTO Responses/Receipts/N417.PYMT (3).pdf; D:/manager/work/2 current_work_catalog.txt
19/747,949 (Conf. [redacted])20 Jul 2026Pending; Acknowledgement Receipt 20 Jul 2026Claim 1 discovery method; paragraph [0010]: 300 diseases, 16 categoriesD:/USPTO Responses/work/N417.pdf

All three are pending and copending on the record date (D:/Rebuttals/_registers/USPTO_REGISTER.json); under first-inventor-to-file, each is dated by its own effective filing date. The as-filed papers of 19/747,949 (D:/USPTO Responses/Applications/19-747-949-diabetes/PATENT_APPLICATION_DIABETES_AND_300_DISEASES.docx, byte-identical to the package-root copy) set out the Alchemy-Based Discovery Methodology over approximately 36,456 compound records (paragraph [0009]), applied to three hundred diseases across sixteen categories (paragraph [0010]); claim 1 claims the computer-implemented method. The 2017 depositions stand beside these filings as dated printed publications. Under 35 U.S.C. 292 the marking is correct while the applications are pending:

Patent pending - U.S. Application Nos. 19/540,453, 19/693,405 and 19/747,949.

5. First to Market - The Dated Public Offering

DateEventWhereSource
24 Nov 2017Invent Depositions first shipped, 1,739 numbered depositionsCreateSpaceD:/manager/book-ocr-2017-invent-depositions/MANIFEST.md; D:/Rebuttals/_registers/COPYRIGHT_REGISTER.json
12 Mar 2026"Open Research: 300-Disease Mechanism Analysis Database" listed, online in Catalog and Searchcri-one.com (old Magento store)D:/manager/export_catalog_product_20260408_165843.csv
19 Apr 2026First-to-Market Provenance Record ledger lists the item as first postedcri-one.com/store/D:/manager/first-to-market/first-to-market-LEDGER.csv
31 Aug 2026Blueprint record SKU 2040 created in Enterprise blueprintscri-one.com (old Magento store)D:/manager/_store/export_catalog_product_20260831_201548.csv
1 Sep 2026Record re-created; kept in the 7 September 2026 exportcri-one.com (old Magento store)D:/manager/export_catalog_product_20260907_110415.csv
4 Sep 2026Delivery file of record dateddelivery copiesD:/special/crione-static/delivery-v2/product_deliverables.csv
8 Oct 2026, 03:55 UTCFirst new-site email campaign to US company prospects startedcri-one.com mail serverC:/Users/cri-one/.claude/projects/D--special/memory/crione-new-server-2026-10-08.md; D:/special/_mailer/campaigns/new-site-2026-10/campaign.json
8 Oct 2026Item page published on the new static sitehttps://cri-one.com/13-disease-research-notes-research.htmlD:/special/crione-static/site-inventory/inventory/item-8459/index.html
8 Oct 2026, 05:06 UTCStripe card Payment Link (created 04:55:58Z) and Buy button publicitem pageD:/special/crione-static/delivery-v2/payment_links_ledger.live.json

6. Copyright

Notice. The package LICENSE carries "Copyright (c) 2026 Christopher Gabriel Brown. All rights reserved." The item page carries "© 2017–2026 Christopher Gabriel Brown" for the underlying inventor corpus, and the four cited 2017 depositions each carry the mark "copyright © 2017 chris g brown" (entries-clean.csv).

Works covered. Text (the 300 documents, index and summary documents, root documentation), drawings (four figures in PDF and SVG, the reference chart), code (60 Python scripts, the PowerShell orchestrator, the cooker generator, 45 G-code files), data (JSON and CSV compilations) and four HTML pages. Copyright arises automatically on fixation (17 U.S.C. 102(a)) and protects this expression, not the ideas or methods it describes (17 U.S.C. 102(b)); method and structure are held by the pending applications and by confidentiality.

Registrations of record. The copyright register verifies 20 registrations of the author's works, effective 1 October 2010 through 15 March 2026, from TX 7-491-093 (invent cloud) to TX 9-504-677 (estimated), including TX 8-396-625 (abstract, effective 9 May 2017) (D:/Rebuttals/_registers/COPYRIGHT_REGISTER.json). They anchor the author's registered corpus. Registration is the gateway to suit for U.S. works (17 U.S.C. 411(a)), and a certificate made within five years of first publication is prima facie evidence of validity (17 U.S.C. 410(c)).

Human authorship. Protection covers the human-authored expression and the author's selection, coordination and arrangement (U.S. Copyright Office registration guidance, March 2023). The protectable expression here is human-authored: the numbered depositions written by Christopher Gabriel Brown, and his selection, coordination and arrangement of this package.

Notice practice. The (c) notice defeats an innocent-infringer defense (17 U.S.C. 401(d)). The owner marks his work in his own name: 102 of the 139 inventory products carry a dated notice in a top-level LICENSE or README, this package among them (copyright register, notice practice).

7. Firm Rebuttals

Challenge 1 - "Screening compounds against diseases by their elements is old. This is not original."

Rebuttal. The founding method, healthy-reference chemistry balanced organ by organ, is in Depositions #148 (2017) and #769 (printed page 181, 24 November 2017). The owner's as-filed papers for 19/747,949 set the package apart from the general field: paragraph [0004] identifies existing approaches as "target-specific screening, molecular docking against known crystal structures, or curated pharmacophore libraries," and paragraph [0005] states that the specific combinations and their systematic derivation by the Alchemy-Based Discovery Methodology "have not been previously described for the disease scope claimed." The six register references are device art with none of this structure. A challenger must produce a dated record earlier than the 2017 depositions disclosing the same combination. None is of record.

Challenge 2 - "Someone else filed first."

Rebuttal. Every application is dated by its own effective filing date. The owner's are dated 13 February, 30 May and 20 July 2026 on USPTO receipts (Evidence 6-8), and his 2017 depositions stand under 35 U.S.C. 102(a)(1) against every later filer on the same subject matter. A challenger must produce a serial number with an earlier effective filing date disclosing a 300-disease, 16-category elemental-correlation corpus over a 36,456-compound database. None is of record.

Challenge 3 - "No patent has issued, so there is nothing to respect."

Rebuttal. Three applications covering this product are pending, and "patent pending" is the correct marking while an application is pending (35 U.S.C. 292). Four further grounds need no issuance: the dated 2017 disclosures, the copyright in the package expression, the confidentiality of delivery, and the purchase term every buyer accepts at checkout.

Challenge 4 - "It was listed publicly, so it is free to use."

Rebuttal. Publication fixes a date; it transfers nothing. The dated listing stands as prior art against every later filer on the same subject matter (35 U.S.C. 102(a)(1)). Copyright in the text, code, data and drawings stays with the author from fixation (17 U.S.C. 102(a)), and the package LICENSE of 2 May 2026 states "NO LICENSE IS GRANTED." The method is held by three pending applications, and the USPTO papers and formal figures of 20 July 2026 travel only inside the delivered package. The full package goes only to paying buyers by private download link under the purchase term "When you buy, you buy the use of that blueprint only."

Challenge 5 - "Software generated the 300 documents, so there is no copyright."

Rebuttal. Protection covers human-authored expression and the author's selection, coordination and arrangement (U.S. Copyright Office registration guidance, March 2023). The founding text is Christopher Gabriel Brown's, written in his numbered 2017 depositions; the selection of 300 conditions, their arrangement in 16 categories with element profiles and the uniform layout every document follows are his choices. The method behind them is held by the pending applications, not by copyright (17 U.S.C. 102(b)).

Challenge 6 - "The dates can be faked."

Rebuttal. The dates rest on third-party records and fixed fingerprints. Invent Depositions carries ISBN 978-1-979767-89-7 and a CreateSpace label showing first shipment on 24 November 2017; Buy Invent 2020 carries Amazon ASIN B086PVSKFM (copyright register). The Internet Archive's own captures date cri-one.com to 28 January 2011 and buyinvent.com, the home of the 2017 catalog, to 5 March 2014 (D:/manager/first-to-market/wayback_evidence.json). The USPTO receipts carry USPTO time stamps (19/747,949: 07/20/2026 07:42:30 PM ET), and the 19/747,949 acknowledgement receipt carries a SHA-512 digest of each filed document. Every file cited here is fingerprinted with SHA-256 in section 8 and D:/Rebuttals/_evidence/8459.sha256, and the First-to-Market evidence bundle built 9 June 2026 re-verified to its SHA-256 fingerprint on 8 October 2026 (D:/manager/first-to-market/first-to-market-CERTIFICATE.html; D:/Rebuttals/_registers/FIRST_TO_MARKET_REGISTER.json).

Challenge 7 - "A 36,456-compound engine and multi-degree probability matrices are inflated numbers."

Rebuttal. Each figure is a count or a computed score, defined in the package's own files and stated exactly. METHODOLOGY.md defines Alchemy Data V2 as "a computational database of 36,456+ elemental combinations"; README.md records 36,456 compounds analyzed and 450,000+ lines of documentation; STATUS.md records multi-degree calculations of the 1st, 12th, 24th, 192th and 240th degree in all 300 files. METHODOLOGY.md defines "Probability" values as "mathematical calculations from the Alchemy system" and discovery scores as database coverage and mechanism overlap. Claim 4 of 19/747,949 recites at least 36,000 compound records. A challenger must show a count the package files do not support. None is of record.

Challenge 8 - "This is an unapproved medical claim."

Rebuttal. The package is a research and discovery IP record and makes no treatment claim. METHODOLOGY.md defines it as "A systematic, computational search for elemental patterns that overlap with disease mechanisms." SAFETY_DISCLAIMER.md opens "THIS IS NOT MEDICAL ADVICE. THIS IS NOT AN FDA-APPROVED TREATMENT.", and each of the 300 disease documents opens with a disclaimer that it holds computational research findings. The public offer uses the approved wording: a computational research corpus for laboratory reference and IP diligence (D:/special/_inventory/descriptions-public/8459.md).

Challenge 9 - "It is just an idea."

Rebuttal. The package is concrete: 300 per-disease documents, 60 Python scripts and a PowerShell orchestrator, 45 G-code recipes with their JSON files, four figures in PDF and SVG, a reference chart, JSON and CSV data and USPTO application papers, 398 files by its own MANIFEST.json. The idea is in the 2017 depositions; this package is its engineered form.

8. Evidence Index

#FileSHA-256 (first 16 hex)What it proves
1D:/special/13-disease-cure-research/LICENSEfcbc156fca651b24Dated notice, exclusive ownership, no license granted
2D:/special/13-disease-cure-research/MANIFEST.json980aa643937e8566Title, 398 files by category, generated 2026-05-02
3D:/special/13-disease-cure-research/STATUS.md63f57e34ec631759Corpus complete 2026-01-12; multi-degree matrices
4D:/special/13-disease-cure-research/METHODOLOGY.md9712065f97cc9e11Defined figures; research corpus, no treatment claim
5D:/USPTO Responses/Applications/19-747-949-diabetes/PATENT_APPLICATION_DIABETES_AND_300_DISEASES.docxa1b0a541e447c03c19/747,949 papers; package root copy hashes identical
6D:/USPTO Responses/work/N417.PYMT.pdfdb26b63fe8f25e0819/540,453 receipt dated 2026-02-13
7D:/USPTO Responses/Receipts/N417.PYMT (3).pdf4982720f8492db7819/693,405 receipt dated 2026-05-30
8D:/USPTO Responses/work/N417.pdf33fc3d922864b74d19/747,949 receipt dated 2026-07-20, Conf. [redacted]
9D:/special/82-alchemy-calc-two/1 light trigger.txt2dcb359de3f1b56dMaster IP register, depositions #148, #373, #486, #769
10D:/manager/book-ocr-2017-invent-depositions/entries-clean.csvad3b87e885814dbb2017 catalog text and copyright marks
11D:/manager/book-ocr-2017-invent-depositions/entries-index.csv9e72c4638df2ca6eDeposition #769 on printed page 181
12D:/manager/book-ocr-2017-invent-depositions/MANIFEST.md2abd4f4b4881f8f6ISBN 978-1-979767-89-7, first shipped 2017-11-24
13D:/manager/export_catalog_product_20260408_165843.csv1ec6bd9793cf5541Store listing created 2026-03-12, online
14D:/special/crione-static/delivery-v2/payment_links_ledger.live.json96abb64653254b86Card Payment Link created 2026-10-08T04:55:58Z
15D:/manager/first-to-market/wayback_evidence.jsona0dde412013594b5Internet Archive first captures of the owner's domains

9. Notice Line

© 2017-2026 Christopher Gabriel Brown (CRI-ONE). All rights reserved. Patent pending - U.S. Application Nos. 19/540,453, 19/693,405 and 19/747,949.

This invention blueprint: Disease Research Notes Research · $982K.
cri-one.com/13-disease-research-notes-research.html
Also sold as part of Cri-One Health 2026 · $10.08B.
Payment is by bank transfer through Stripe.
Go to cart
Page 1 of 1
0% read